Dr Nagham Ailabouni is a Postdoctoral Research Fellow at the Quality Use of Medicines and Pharmacy Research Centre. She is a New Zealand registered pharmacist with clinical experience in various healthcare settings. She completed her PhD titled "Deprescribing in Older New Zealanders" from the University of Otago, Dunedin in 2018. Her research foci include person-centred deprescribing, discontinuing anticholinergic and sedative medications in older people, and implementation science. In 2020, Dr Ailabouni was selected as an awardee of the inaugural US Deprescribing Network Junior Investigator Intensive Program for deprescribing research. In total, Dr Ailabouni has led six consumer-centric translational research projects... Read more
About me
Dr Nagham Ailabouni is a Postdoctoral Research Fellow at the Quality Use of Medicines and Pharmacy Research Centre. She is a New Zealand registered pharmacist with clinical experience in various healthcare settings. She completed her PhD titled "Deprescribing in Older New Zealanders" from the University of Otago, Dunedin in 2018. Her research foci include person-centred deprescribing, discontinuing anticholinergic and sedative medications in older people, and implementation science. In 2020, Dr Ailabouni was selected as an awardee of the inaugural US Deprescribing Network Junior Investigator Intensive Program for deprescribing research. In total, Dr Ailabouni has led six consumer-centric translational research projects focussed on improving medication appropriateness in older adults in North America and Australasia.
About me
| Date | Title |
|---|---|
| 22/01/2021 |
GeriPal Podcast - A Geriatrics and Palliative Care Blog "Medications Safety/Quality Update" , https://www.geripal.org/2021/01/medications-safetyquality-update.html |
| 12/05/2018 |
Study Dunedin - Dr Nagham Ailabouni , https://www.youtube.com/watch?v=FsVbTTAYo0U |
About me
Doctor of Philosophy University of Otago
Postgraduate Certificate in Pharmacy University of Otago
Bachelor of Pharmacy University of Otago
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2020 |
Open access
7
17
|
| 2019 |
24
23
140
|
| 2017 |
Open access
12
14
28
|
| 2016 |
31
28
12
|
| 2016 |
Open access
79
68
16
|
| Year | Output |
|---|---|
| 2021 |
19
|
| 2021 |
14
|
| 2021 |
16
|
| 2020 |
Open access
7
17
|
| 2020 |
1
1
20
|
| 2020 |
5
4
8
|
| 2019 |
24
23
140
|
| 2019 |
3
2
|
| 2019 |
Open access
1
1
18
|
| 2017 |
Open access
12
14
28
|
| 2017 |
4
3
2
|
| 2016 |
7
7
2
|
| 2016 |
31
28
12
|
| 2016 |
Open access
79
68
16
|
| 2016 |
4
4
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Duke University | UNITED STATES |
| Flinders University | AUSTRALIA |
| McMaster University | CANADA |
| RTI International | UNITED STATES |
| University of Bath | UNITED KINGDOM |
| University of Otago | NEW ZEALAND |
| University of Pennsylvania | UNITED STATES |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| University of Washington | UNITED STATES |
| University of Washington, Seattle | UNITED STATES |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Branch President, South CanterburyPharmaceutical Society of New Zealand (PSNZ) |
2018 |
Branch President, South CanterburyPharmaceutical Society of New Zealand (PSNZ) |
2017 |
Branch President, OtagoPharmaceutical Society of New Zealand (PSNZ) |
2016 |
Branch President, South CanterburyPharmaceutical Society of New Zealand (PSNZ) |
2016 |
Invited Speaker, Medicine Information SIG MeetingNew Zealand Hospital Pharmacist Association (NZHPA) |
2016 |
Branch President, OtagoPharmaceutical Society of New Zealand (PSNZ) |
2015 |
Branch President, OtagoPharmaceutical Society of New Zealand (PSNZ) |
2014 |
